Weiss Multi-Strategy Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,927	Closed	-$1.31M	–	810
2022 Q1	$1.31M	Sell	15,927 -4,109	-21%	-$420K	0.03%	462
2021 Q4	$2.94M	Buy	20,036 +10,036	+100%	+$1.56M	0.07%	324
2021 Q3	$1.77M	Sell	10,000 -1,114	-10%	-$179K	0.04%	433
2021 Q2	$1.79M	Buy	+11,114	New	+$1.78M	0.04%	416
2021 Q1	–	Sell	-929	Closed	-$204K	–	871
2020 Q4	$204K	Sell	929 -2,076	-69%	-$449K	﹤0.01%	646
2020 Q3	$499K	Sell	3,005 -9,288	-76%	-$1.27M	0.01%	479
2020 Q2	$1.4M	Sell	12,293 -11,291	-48%	-$1.1M	0.04%	371
2020 Q1	$1.81M	Buy	23,584 +10,584	+81%	+$949K	0.07%	258
2019 Q4	$1.68M	Buy	+13,000	New	+$1.25M	0.03%	442

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Weiss Multi-Strategy Advisers's MRTX Position: Q2 2022 in Review

Weiss Multi-Strategy Advisers sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2022, closing a stake of 15,927 shares — an estimated $1.31M sold.

Weiss Multi-Strategy Advisers first reported a position in MRTX in Q4 2019 and held it in 9 quarters. The position peaked at $2.94M in Q4 2021. 230 funds tracked by Wall St. Rank hold MRTX as of Q2 2022.

Weiss Multi-Strategy Advisers reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 15,927 Mirati Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1.31M.
Weiss Multi-Strategy Advisers first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Weiss Multi-Strategy Advisers's Mirati Therapeutics, Inc. Common Stock position peaked at $2.94M in Q4 2021.
230 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.